CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR CERTAIN PORTIONS OF THIS EXHIBIT. CONFIDENTIAL PORTIONS OF THIS EXHIBIT ARE DESIGNATED BY [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.Manufacturing Services Agreement • March 3rd, 2017 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 3rd, 2017 Company IndustrySciClone Pharmaceuticals International Ltd., Ugland House, South Church Street George Town, Grand Cayman, Cayman Islands, USA (“Customer”)
CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR CERTAIN PORTIONS OF THIS EXHIBIT. CONFIDENTIAL PORTIONS OF THIS EXHIBIT ARE DESIGNATED BY [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.Manufacturing Services Agreement • August 9th, 2016 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledAugust 9th, 2016 Company IndustrySciClone Pharmaceuticals International Ltd., Ugland House, South Church Street George Town, Grand Cayman, Cayman Islands, USA (“Customer”)